# Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

> **NCT00757588** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 455 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Saxagliptin, 5 mg + insulin
- **DRUG:** Placebo + insulin

## Key facts

- **NCT ID:** NCT00757588
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2015-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00757588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00757588, "Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00757588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*